366 related articles for article (PubMed ID: 22202099)
1. Insulin resistance, metabolic stress, and atherosclerosis.
Pansuria M; Xi H; Li L; Yang XF; Wang H
Front Biosci (Schol Ed); 2012 Jan; 4(3):916-31. PubMed ID: 22202099
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance, hyperglycemia, and atherosclerosis.
Bornfeldt KE; Tabas I
Cell Metab; 2011 Nov; 14(5):575-85. PubMed ID: 22055501
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance and atherosclerosis.
Nigro J; Osman N; Dart AM; Little PJ
Endocr Rev; 2006 May; 27(3):242-59. PubMed ID: 16492903
[TBL] [Abstract][Full Text] [Related]
4. A spontaneously hypertensive diet-induced atherosclerosis-prone mouse model of metabolic syndrome.
Dragoljevic D; Veiga CB; Michell DL; Shihata WA; Al-Sharea A; Head GA; Murphy AJ; Kraakman MJ; Lee MKS
Biomed Pharmacother; 2021 Jul; 139():111668. PubMed ID: 34243630
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance and the endothelium.
Quiñones MJ; Nicholas SB; Lyon CJ
Curr Diab Rep; 2005 Aug; 5(4):246-53. PubMed ID: 16033673
[TBL] [Abstract][Full Text] [Related]
6. Molecular changes in hepatic metabolism in ZDSD rats-A new polygenic rodent model of obesity, metabolic syndrome, and diabetes.
Han L; Bittner S; Dong D; Cortez Y; Bittner A; Chan J; Umar M; Shen WJ; Peterson RG; Kraemer FB; Azhar S
Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165688. PubMed ID: 31987840
[TBL] [Abstract][Full Text] [Related]
7. Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease.
Rask-Madsen C; Kahn CR
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2052-9. PubMed ID: 22895666
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance: Review of the underlying molecular mechanisms.
Yaribeygi H; Farrokhi FR; Butler AE; Sahebkar A
J Cell Physiol; 2019 Jun; 234(6):8152-8161. PubMed ID: 30317615
[TBL] [Abstract][Full Text] [Related]
9. Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity.
Bakker W; Eringa EC; Sipkema P; van Hinsbergh VW
Cell Tissue Res; 2009 Jan; 335(1):165-89. PubMed ID: 18941783
[TBL] [Abstract][Full Text] [Related]
10. Role of insulin resistance and hyperglycemia in the development of atherosclerosis.
Bansilal S; Farkouh ME; Fuster V
Am J Cardiol; 2007 Feb; 99(4A):6B-14B. PubMed ID: 17307054
[TBL] [Abstract][Full Text] [Related]
11. Membrane and soluble endoglin role in cardiovascular and metabolic disorders related to metabolic syndrome.
Vicen M; Igreja Sá IC; Tripská K; Vitverová B; Najmanová I; Eissazadeh S; Micuda S; Nachtigal P
Cell Mol Life Sci; 2021 Mar; 78(6):2405-2418. PubMed ID: 33185696
[TBL] [Abstract][Full Text] [Related]
12. The Role of Insulin Receptor Isoforms in Diabetes and Its Metabolic and Vascular Complications.
Escribano O; Beneit N; Rubio-Longás C; López-Pastor AR; Gómez-Hernández A
J Diabetes Res; 2017; 2017():1403206. PubMed ID: 29201918
[TBL] [Abstract][Full Text] [Related]
13. Coordinated augmentation of NFAT and NOD signaling mediates proliferative VSMC phenotype switch under hyperinsulinemia.
Shiny A; Regin B; Mohan V; Balasubramanyam M
Atherosclerosis; 2016 Mar; 246():257-66. PubMed ID: 26814423
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive account of insulin and LDL receptor activity over the years: A highlight on their signaling and functional role.
Chandra NC
J Biochem Mol Toxicol; 2021 Sep; 35(9):e22840. PubMed ID: 34227185
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance aggravates atherosclerosis by reducing vascular smooth muscle cell survival and increasing CX3CL1/CX3CR1 axis.
Martínez-Hervás S; Vinué A; Núñez L; Andrés-Blasco I; Piqueras L; Real JT; Ascaso JF; Burks DJ; Sanz MJ; González-Navarro H
Cardiovasc Res; 2014 Jul; 103(2):324-36. PubMed ID: 24788416
[TBL] [Abstract][Full Text] [Related]
16. Adipocyte Dynamics and Reversible Metabolic Syndrome in Mice with an Inducible Adipocyte-Specific Deletion of the Insulin Receptor.
Sakaguchi M; Fujisaka S; Cai W; Winnay JN; Konishi M; O'Neill BT; Li M; García-Martín R; Takahashi H; Hu J; Kulkarni RN; Kahn CR
Cell Metab; 2017 Feb; 25(2):448-462. PubMed ID: 28065828
[TBL] [Abstract][Full Text] [Related]
17. Effects of insulin on the vasculature.
Breen DM; Giacca A
Curr Vasc Pharmacol; 2011 May; 9(3):321-32. PubMed ID: 20807190
[TBL] [Abstract][Full Text] [Related]
18. Pericytopathy: oxidative stress and impaired cellular longevity in the pancreas and skeletal muscle in metabolic syndrome and type 2 diabetes.
Hayden MR; Yang Y; Habibi J; Bagree SV; Sowers JR
Oxid Med Cell Longev; 2010; 3(5):290-303. PubMed ID: 21150342
[TBL] [Abstract][Full Text] [Related]
19. Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.
Cooper SA; Whaley-Connell A; Habibi J; Wei Y; Lastra G; Manrique C; Stas S; Sowers JR
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2009-23. PubMed ID: 17586614
[TBL] [Abstract][Full Text] [Related]
20. Pathway-selective insulin resistance and metabolic disease: the importance of nutrient flux.
Otero YF; Stafford JM; McGuinness OP
J Biol Chem; 2014 Jul; 289(30):20462-9. PubMed ID: 24907277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
